Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Sunbelt Securities Inc.

Sunbelt Securities Inc. reduced its stake in shares of Teladoc Health, Inc. (NYSE:TDOC) by 32.4% during the 3rd quarter, HoldingsChannel reports. The firm owned 12,259 shares of the health services provider’s stock after selling 5,865 shares during the quarter. Sunbelt Securities Inc.’s holdings in Teladoc Health were worth $113,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the stock. Point72 Asset Management L.P. lifted its position in Teladoc Health by 57.8% during the third quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock worth $76,803,000 after buying an additional 3,063,172 shares in the last quarter. Rubric Capital Management LP acquired a new stake in shares of Teladoc Health in the 2nd quarter worth $45,267,000. Clearline Capital LP raised its holdings in shares of Teladoc Health by 395.6% during the 2nd quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock worth $42,682,000 after acquiring an additional 3,483,665 shares during the period. Geode Capital Management LLC boosted its position in shares of Teladoc Health by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock valued at $36,042,000 after acquiring an additional 56,864 shares during the last quarter. Finally, Assenagon Asset Management S.A. purchased a new stake in shares of Teladoc Health in the third quarter valued at about $15,801,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, insider Carlos Nueno sold 2,389 shares of Teladoc Health stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the sale, the insider now directly owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. The trade was a 45.25 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.95% of the stock is currently owned by company insiders.

Teladoc Health Trading Up 2.2 %

Shares of NYSE TDOC opened at $10.42 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The stock’s 50-day moving average is $9.79 and its two-hundred day moving average is $9.16. Teladoc Health, Inc. has a 1-year low of $6.76 and a 1-year high of $22.54.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.10. The business had revenue of $640.51 million during the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Evercore ISI boosted their target price on shares of Teladoc Health from $8.00 to $9.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Jefferies Financial Group upped their price objective on Teladoc Health from $8.00 to $10.00 and gave the company a “hold” rating in a report on Tuesday, September 17th. The Goldman Sachs Group initiated coverage on Teladoc Health in a research note on Friday, November 15th. They set a “buy” rating and a $14.00 target price for the company. JPMorgan Chase & Co. reduced their target price on Teladoc Health from $16.00 to $9.00 and set a “neutral” rating on the stock in a research report on Monday, August 26th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $10.00 price target on shares of Teladoc Health in a report on Tuesday, August 20th. Fourteen analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, Teladoc Health has an average rating of “Hold” and an average target price of $12.24.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.